Acco Brands

( ABD) downgraded at Suntrust from Buy to Neutral. Estimates also cut, to reflect the company's new guidance. Credibility concern remains.

Alpha Natural Resources


downgraded at FBR to a Market Perform rating following a 40% run in the last six weeks. Target remains $28.50.


(BWA) - Get Report

downgraded at Baird from Neutral to Underperform. Valuation call, based on an $82 price target. Stock is already pricing in expected future growth.


(C) - Get Report

downgraded at Deutsche Bank to a Sell from Buy as new management leaves Office of Chairman intact despite performance that has repeatedly fallen short of peers.


(COST) - Get Report

downgraded at UBS to Neutral rating from Buy. However, price target lifts to $75 from $68 and FY08 eps estimates upped to $3.00 from $2.94.

Coldwater Creek


downgraded at Wachovia to Market Perform. Company continues to post relatively worse numbers than its peers. Buyback has also yet to help turn things around.


( LNCR) downgraded at Citigroup from Buy to Hold. $37 price target. Medicare cap likely to be cut for oxygen.

Massey Energy

( MEE) downgraded at FBR to an Underperform rating based on valuation following 57% rally from August 8 lows. Target is $22.

Millennium Pharma

( MLNM) upgraded at Baird from Neutral to Outperform. $14 price target. Market has low expectations for the company and Velcade, but new indications and JNJ's promotion should finally begin to ramp.

National Financial


downgraded at Merrill from Buy to Neutral. Valuation call, as the company also has near-term earnings risk.

NII Holdings

TST Recommends

(NIHD) - Get Report

upgraded at UBS to Buy rating from Neutral. Price target and FY08 eps estimates hold at $85.00 and $3.01, respectively.

Blue Nile


downgraded at Citigroup from Hold to Sell. $88 price target. Little visibility on third quarter results, and recent traffic trends suggest downside potential to earnings.

PharmaNet Development

( PDGI) upgraded at Jefferies to Buy rating from Hold. Price target lifts to $39 from $30 and FY08 eps estimates upped to $1.71 from $1.51.


(S) - Get Report

upgraded at Wachovia to Outperform. Stock is down 9% since last June, and is likely within 6 months of a sustainable turnaround in subscriber growth.

Shaw Group

( SGR) downgraded at Citigroup from Buy to Hold. Valuation call, based on a $74 price target. Positive nuclear catalysts remain.



upgraded at CIBC from Sector Perform to Outperform. Grocers have been unfairly punished, and the company continues to deliver strong numbers. $40 price target.



downgraded at Jefferies to Hold rating from Buy. Price target lifts to $27 from $25 and FY08 eps estimates dips to $0.90 from $0.98.


Hartford Fin.

(HIG) - Get Report

cut from Focus List at JP Morgan. $109 price target. No longer expect 20% upside over the next year. Maintain Overweight rating.

JB Hunt

(JBHT) - Get Report

2007 estimates cut at Deutsche Bank to $1.47 a share on lower expected profitability at dedicated and core trucking. Maintained Hold rating.

Zion Bancorporation

(ZION) - Get Report

2007 estimates cut at FBR by 26 cents to $5.43 a share due to weak Arizona housing market. Maintained Market Perform rating.